ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.
Saved in:
| Title: | ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer. |
|---|---|
| Authors: | Mota I; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Patrucco E; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Mastini C; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bergaggio E; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Cheong TC; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Leonardi G; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Karaca-Atabay E; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Campisi M; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Poggio T; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Menotti M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Ambrogio C; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Longo DL; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Molecular Imaging Center, University of Torino, Torino, Italy.; Institute of Biostructures and Bioimaging (IBB), National Research Council of Italy (CNR), Torino, Italy., Klaeger S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Keshishian H; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sztupinszki ZM; Danish Cancer Society Research Center, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA., Szallasi Z; Danish Cancer Society Research Center, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Department of Bioinformatics, Semmelweis University, Budapest, Hungary., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Computer Science, Metropolitan College, Boston University, Boston, MA, USA.; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Duke-Cohan JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, USA., Reinhold B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, USA., Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Moynihan KD; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Reinherz EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA., Voena C; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Blasco RB; Department of Pathology, Boston Children's Hospital, Boston, MA, USA. rafael.b.blasco@gmail.com., Chiarle R; Department of Pathology, Boston Children's Hospital, Boston, MA, USA. roberto.chiarle@childrens.harvard.edu.; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. roberto.chiarle@childrens.harvard.edu. |
| Source: | Nature cancer [Nat Cancer] 2023 Jul; Vol. 4 (7), pp. 1016-1035. Date of Electronic Publication: 2023 Jul 10. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
